Israeli and U.S. researchers have found that computer aided-detection systems can boost the accuracy of chest radiography for lung cancer, especially when the procedures are performed by inexperienced readers.
Israeli and U.S. researchers have found that computer aided-detection systems can boost the accuracy of chest radiography for lung cancer, especially when the procedures are performed by inexperienced readers.
Although chest CT represents the de facto imaging standard for lung cancer diagnosis, many hospitals in the U.S. and most around the developing world still rely on cheaper digital or analog chest radiography systems. The use of a CAD device for detection of lung nodules on digital chest radiographs improves sensitivity, particularly of less experienced readers, and can function as a second reader, according to Dr. Dorith Shaham, a radiologist at the Hadassah-Hebrew University Medical Center in Jerusalem.
Shaham's retrospective study involved 77 digital chest radiographs from health facilities in Europe and the U.S. The DR samples were correlated with chest CT by two independent expert readers who established the "ground truth" for the presence and location of masses and lung nodules greater than 5 mm. Three radiologists with various levels of expertise - a resident, general radiologist, and thoracic radiologist - subsequently read these cases randomly and marked apparent lung masses and nodules greater than 5 mm without CT correlation. Readers relied on a prototype detection system that generated CAD marks for all DR images.
The investigators found that the CAD device increased the detection rate of nodules for all readers but most significantly for the resident. Results were presented at the 2007 RSNA meeting.
Researchers established the ground truth based on 46 findings from 36 digital radiographs. Thirty-nine findings were nodules 5 mm or larger. Using the CAD system, the general radiologist detected 23 nodules compared with 20 nodules without CAD. The thoracic radiologist detected 22 nodules compared with 20 nodules without CAD.
The detection rate for the resident, on the other hand, increased by 10.3% and was statistically significant (p<0.046). The resident detected 18 nodules with CAD assistance and 14 without CAD.
"The increase was inversely proportional to the expertise of the reader," Shaham said.
In a separate study, researchers at the University of Chicago sought to establish the true rate of detection of a digital radiography system versus the "accidental" markings that can be attributed to this technology when used in lung cancer detection.
Lead investigator Dr. Feng Li, Ph.D., and colleagues retrospectively applied CAD to 34 digital chest radiographs with malignant nodules not mentioned in their respective reports. The researchers defined CAD markings as true detections only when their center was within the area of a lesion boundary. Detection was deemed accidental if the center point of the CAD marking was not within the lesion boundary, even if the lesion was located completely or partially within the 5-cm circle provided by the marking.
The investigators found the reported sensitivity of the CAD system can vary by as much as 100% depending on the precise definition of true versus false marks. The same criterion could yield smaller, though substantial specificity.
CAD found a total of 211 marks, with a sensitivity of only 26% and an average of 3.6 false positives per radiograph. If the criterion was expanded to include lesions located completely within the circles, the sensitivity for cancers marked increased to 41% with 3.4 false-positive marks per image. If the criterion was again expanded to include lesions located at least partially within the circles, the sensitivity increased to 53% with 3.3 false-positive marks per image. Specificity changed only marginally as more of the lesions farther away from the center of the markings were excluded.
"In evaluating CAD systems, it is important to understand how their apparent accuracy can be influenced by the specific criteria that are used to determine sensitivity and specificity," Li said.
For more information from the Diagnostic Imaging archives:
Siemens' CAD shines at RSNA 2007
NCI consortium proposes standardized lung interpretation for CAD "truth" assessment
CAD expands to aid imaging in niches throughout body
Mammography Study: Can Stand-Alone AI Enhance Detection of Interval Breast Cancer?
August 28th 2024Identifying over 23 percent of interval breast cancers with a 96 percent sensitivity in mammography interpretation, an emerging AI software also facilitated correct localization in over 75 percent of cases involving interval breast cancer, according to new research.
Can AI Facilitate Effective Triage for Supplemental Breast MRI After Negative Mammography Screening?
July 10th 2024The AISmartDensity software facilitated a cancer detection rate (CDR) with breast MRI that was nearly four times higher than the CDR previously reported in trials involving traditional breast density assessment.